Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-001284

Chief Development Officer acquired 38,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
See Tai Sandi Chief Development Officer 2025-01-07 Grant or award +38,750 55,375 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
See Tai Sandi Chief Development Officer 2025-01-07 Grant or award · Stock Option (right to buy) +77,500 77,500 D: show line 2 in the form
Loading xslF345X05/form4-01102025_040103.xml…